Press Releases | Medtronic

Month Year

Email alerts

Aug 5, 2011

Medtronic to Webcast Annual Shareholder Meeting

MINNEAPOLIS, Aug 05, 2011 (BUSINESS WIRE) -- Medtronic investors and other interested parties are invited to participate in a live video webcast of the Medtronic Annual Shareholder Meeting on...
Aug 3, 2011

Medtronic Engages Yale University to Oversee Independent, Systematic Reviews of Recombinant Bone Morphogenic Protein-2

First of its Kind Post-Review Website to Provide Scientific Access to Full Clinical Data

MINNEAPOLIS, Aug 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. [NYSE: MDT] announced today that it has provided a grant to Yale University to conduct two fully independent, third-party systematic...
Aug 1, 2011

Medtronic Receives FDA Approval for Advisa DR MRI(TM) SureScan(R) Pacing System Clinical Trial

Investigational Second-Generation Device Reinforces Medtronic's Commitment to Innovative Implantable Cardiac Devices Designed for Use in MRI Environment

MINNEAPOLIS, Aug 01, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval for its Investigational Device Exemption (IDE) application...
Jul 25, 2011

Medtronic Resolute(R) Drug-Eluting Stent Shows Superiority to Taxus(R) DES in Study of Patients with Coronary Artery Disease

Presented at CVIT by Principal Investigator Shigeru Saito, One-Year Data from RESOLUTE Japan Support Company's PMDA Submission for Product Approval

MINNEAPOLIS, Jul 25, 2011 (BUSINESS WIRE) -- TheResolute(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT), showed superiority to Boston Scientific Corp.'s Taxus(R) DES on the primary...
Jul 21, 2011

Medtronic Announces 2011 "Global Heroes"

Distance Runners from Around the World Who Benefit from Medical Technology to Run Medtronic Twin Cities Marathon Events this Fall

MINNEAPOLIS, Jul 21, 2011 (BUSINESS WIRE) -- Twenty-five long-distance runners who benefit from medical technology will be honored as "Medtronic Global Heroes" when they run the Medtronic Twin...
Jul 11, 2011

Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure

Patient Enrollment in U.S. Clinical Trial of Renal Denervation with Symplicity(R) Catheter System(TM) for Treating Resistant Hypertension to Start Soon

MINNEAPOLIS, Jul 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY...
Jul 8, 2011

Medtronic Issues Communication about the Potential for Reduced Battery Performance in a Small Percentage of SynchroMed(R) II Implantable Drug Infusion Pumps

Update to July 2009 Letter to Healthcare Professionals

MINNEAPOLIS, Jul 08, 2011 (BUSINESS WIRE) -- As part of its ongoing commitment to keep patients and physicians informed about product performance and safety, Medtronic, Inc. (NYSE: MDT) is issuing...
Jul 7, 2011

Medtronic To Acquire Salient Surgical Technologies, Inc.

Medtronic Targets Leadership Role in Advanced Energy Surgical Technologies

MINNEAPOLIS, Jul 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire Salient Surgical Technologies, Inc., the leader...
Jul 7, 2011

Medtronic To Acquire PEAK Surgical, Inc.

Medtronic Targets Leadership Role in Advanced Energy Surgical Technologies

MINNEAPOLIS, Jul 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire PEAK Surgical, Inc., a recognized leader in the...
Jul 1, 2011

Medtronic Introduces the CD HORIZON(R) Fenestrated Screw Spinal System

Europe first in line to receive Medtronic's innovative product

MEMPHIS, Tenn., Jul 01, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the European launch of the CD HORIZON(R) Fenestrated Screw Spinal System, which is used in conjunction...

Show per page